Clinical Trial Update: PROCEDYTE: Depocyte® Administration (Liposomal Cytarabine) as Prophylaxis of Neuromeningeal Infiltration in Acute Lymphoblastic Leukemia [Phase 3]

View source ↗

Summary

A Phase 3 trial of Depocyte (liposomal cytarabine) for prophylaxis of neuromeningeal infiltration in acute lymphoblastic leukemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Depocyte

Snippet

Sponsor: PETHEMA Foundation | Conditions: Acute Lymphoblastic Leukemia | Phase 3 | Status: TERMINATED